Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (191-200 of 252) with videos related to

Pageof 26
Sort By:
BMC Cancer|March 20, 2025
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trialRobin J Young, Amanda Kirkham, Joshua Savage, et al.
Annals of Internal Medicine|December 19, 2007
Brief communication: rituximab in HIV-associated multicentric Castleman diseaseMark Bower, Tom Powles, Sarah Williams, et al.
Journal of the International AIDS Society|November 14, 2014
Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDALeah Shepherd, Alvaro Humberto Borges, Lene Ravn, et al.
HIV Medicine|October 20, 2025
Integrase inhibitors and paclitaxel for Kaposi sarcoma: Clinical relevance of pharmacological interactionNiroshan Dayalan, Suki Leung, Katherine Dahill, et al.
American Journal of Hematology|January 15, 2025
Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion LymphomaKathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, et al.
Leukemia|April 23, 2026
Hemophagocytic lymphohistiocytosis in HIV-related lymphomas: a multicentre retrospective cohort studyPascal Migaud, Alessia Dalla Pria, Daniela Drauz, et al.
Oncology|September 18, 2017
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular CarcinomaDavid J Pinato, Marco Merli, Alessia Dalla Pria, et al.
Journal of Hepatology|May 2, 2025
Hepatocellular carcinoma in people living with HIVClaudia Am Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, et al.
AIDS (London, England)|March 3, 2015
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapyFerras Alwan, Annie He, Silvia Montoto, et al.
Clinical Lung Cancer|November 11, 2010
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaborationGabriela A D'Jaen, Liron Pantanowitz, Mark Bower, et al.
Pageof 26

Showing results (191-200 of 252) with videos related to

Sort By:
Pageof 26
BMC Cancer|March 20, 2025
Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trialRobin J Young, Amanda Kirkham, Joshua Savage, et al.
Annals of Internal Medicine|December 19, 2007
Brief communication: rituximab in HIV-associated multicentric Castleman diseaseMark Bower, Tom Powles, Sarah Williams, et al.
Journal of the International AIDS Society|November 14, 2014
Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDALeah Shepherd, Alvaro Humberto Borges, Lene Ravn, et al.
HIV Medicine|October 20, 2025
Integrase inhibitors and paclitaxel for Kaposi sarcoma: Clinical relevance of pharmacological interactionNiroshan Dayalan, Suki Leung, Katherine Dahill, et al.
American Journal of Hematology|January 15, 2025
Primary Effusion Lymphoma Prognostic Score (PEL-PS): A Validated International Prognostic Score in HIV-Associated Primary Effusion LymphomaKathryn Lurain, Ramya Ramaswami, Eric Oksenhendler, et al.
Leukemia|April 23, 2026
Hemophagocytic lymphohistiocytosis in HIV-related lymphomas: a multicentre retrospective cohort studyPascal Migaud, Alessia Dalla Pria, Daniela Drauz, et al.
Oncology|September 18, 2017
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular CarcinomaDavid J Pinato, Marco Merli, Alessia Dalla Pria, et al.
Journal of Hepatology|May 2, 2025
Hepatocellular carcinoma in people living with HIVClaudia Am Fulgenzi, Alessia Dalla Pria, Alberto Giovanni Leone, et al.
AIDS (London, England)|March 3, 2015
Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapyFerras Alwan, Annie He, Silvia Montoto, et al.
Clinical Lung Cancer|November 11, 2010
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaborationGabriela A D'Jaen, Liron Pantanowitz, Mark Bower, et al.
Pageof 26